These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 24578624)
1. Development of a controlled release of salicylic acid loaded stearic acid-oleic acid nanoparticles in cream for topical delivery. Woo JO; Misran M; Lee PF; Tan LP ScientificWorldJournal; 2014; 2014():205703. PubMed ID: 24578624 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers for the topical delivery of tretinoin. Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827 [TBL] [Abstract][Full Text] [Related]
4. Preparation of Salicylic Acid Loaded Nanostructured Lipid Carriers Using Box-Behnken Design: Optimization, Characterization and Physicochemical Stability. Pantub K; Wongtrakul P; Janwitayanuchit W J Oleo Sci; 2017; 66(12):1311-1319. PubMed ID: 29199206 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Mohanty B; Majumdar DK; Mishra SK; Panda AK; Patnaik S Pharm Dev Technol; 2015 Jun; 20(4):458-64. PubMed ID: 24490828 [TBL] [Abstract][Full Text] [Related]
6. Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior. Rehman M; Madni A; Ihsan A; Khan WS; Khan MI; Mahmood MA; Ashfaq M; Bajwa SZ; Shakir I Int J Nanomedicine; 2015; 10():2805-14. PubMed ID: 25897224 [TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system. Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712 [TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. Shah RM; Malherbe F; Eldridge D; Palombo EA; Harding IH J Colloid Interface Sci; 2014 Aug; 428():286-94. PubMed ID: 24910064 [TBL] [Abstract][Full Text] [Related]
10. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices. Pawar AA; Chen DR; Venkataraman C Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694 [TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin Controlled-Solid Lipid Nanoparticles: Characterization, In Vitro Release, and Antibacterial Activity Assessment. Shazly GA Biomed Res Int; 2017; 2017():2120734. PubMed ID: 28194408 [TBL] [Abstract][Full Text] [Related]
12. Studies on the cyclosporin A loaded stearic acid nanoparticles. Zhang Q; Yie G; Li Y; Yang Q; Nagai T Int J Pharm; 2000 May; 200(2):153-9. PubMed ID: 10867245 [TBL] [Abstract][Full Text] [Related]
13. Development of Houttuynia cordata Extract-Loaded Solid Lipid Nanoparticles for Oral Delivery: High Drug Loading Efficiency and Controlled Release. Kim JH; Baek JS; Park JK; Lee BJ; Kim MS; Hwang SJ; Lee JY; Cho CW Molecules; 2017 Dec; 22(12):. PubMed ID: 29236057 [No Abstract] [Full Text] [Related]
15. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles. Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394 [TBL] [Abstract][Full Text] [Related]
16. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Noor NM; Sheikh K; Somavarapu S; Taylor KMG Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472 [TBL] [Abstract][Full Text] [Related]
18. [Orthogonal experiments for optimizing the formulation and preparation conditions of temozolomide solid lipid nanoparticles]. Dou M; Huang G; Xi Y; Zhang N Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Oct; 25(5):1141-5. PubMed ID: 19024463 [TBL] [Abstract][Full Text] [Related]
19. Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability. Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Valizadeh H; Maniruzzaman M; Farmoudeh A; Nokhodchi A AAPS PharmSciTech; 2017 Jul; 18(5):1469-1474. PubMed ID: 27834054 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]